Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma: A Cochrane systematic review
Author(s) Crossingham I.; Turner S.; Richardson R.; Webb P.; Ramakrishnan S. et al.
Source BMJ Evidence-Based Medicine; 2021
Background: In people with mild asthma poor adherence to regular therapy is common and increases the risk of exacerbations, morbidity and mortality. The use of fixed-dose combination inhalers containing an inhaled corticosteroid (ICS) and a fast-acting beta2-agonist (FABA) is established in moderate asthma, but they may also have potential utility in mild asthma. Objective(s): To evaluate the efficacy and safety of single combined FABA/ICS inhaler only used as needed in people with mild asthma. Design and setting: Cochrane meta-analysis of available trial data. Participant(s): Children aged 12+ and adults with mild asthma.
The following databases were searched:
EMBASE, MEDLINE, PsycINFO, BNI, CINAHL,
to find ELHT staff publications
Staffed Opening Hours
24/7 access to both libraries is available - please see library staff